SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Bioequivalence and other unresolved issues in generic drug substitution · Study

ArticleShelves

ArticleBioequivalence and other unresolved issues in generic drug substitution

Peter Meredith2003

Article2003

Bioequivalence and other unresolved issues in generic drug substitution

213 citations·0/0 files stored·Clinical Therapeutics

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Pharmaceutical studies and practices Biosimilars and Bioanalytical Methods

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 213 citations exist upstream.

Cited by

2006Patients’ attitudes towards and experiences of generic drug substitution in Norway 2006Are there potential problems with generic substitution of antiepileptic drugs?2010An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland 2020The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China 2007What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice 2013Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

Details

Year2003

Typearticle

Published2003-11-01

VenueClinical Therapeutics

ISSN-L0149-2918

Languageen

Citations213

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/s0149-2918(03)80340-5

openalex_workW1976542298

Links

Imported from OpenAlex (CC0) — nothing here is generated.